SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to high volume and price volatility, sparking discussions around potential insider selling following a lock-up period expiration. The community is debating whether the dip represents a buying opportunity or a sign of further declines, with some citing oversold conditions and potential for a rebound. Others express concern over the company's fundamentals and the impact of potential dilution.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending as traders discuss the potential for a short squeeze, pointing to its high short interest and unusual options activity. Some believe the company's AI-driven drug discovery platform and partnerships with companies like NVDA could be a catalyst. Others remain cautious, noting concerns around cash burn and insider selling.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently closed $75 million investment focused on AI connectivity, fueling speculation about the institutional investor behind the deal and potential strategic implications for the company. Community discussions revolve around POET's role in addressing bottlenecks in AI data centers and the potential for partnerships or M&A activity in the AI hardware space. Bullish sentiment is high, with many anticipating significant upside potential and comparing it to other high-growth tech sectors.

American Rebel Holdings, Inc. engages in the design and marketing of branded safes, and personal security and self-defense products. It also designs and manufactures branded apparel and accessories. The company was founded on December 15, 2014 and is headquartered in Brentwood, TN.

American Rebel Holdings Inc

American Rebel Holdings ($AREB) is trending amidst discussions around trading halts, potential breakout points, and the stock's history of multi-day runs. Community members are actively debating its short-squeeze potential and consolidation patterns, with some pointing to a possible 'squirt' to higher levels. Additionally, the buzz around recent biotech releases is contributing to the heightened interest in $AREB.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid renewed buyout speculation and anticipation for upcoming trial catalysts, especially following competitor acquisitions in the obesity and NASH space. Community members highlight VKTX's strong pipeline, potential for best-in-class efficacy, and a growing sense that the market is undervaluing the stock relative to recent deals. A possible short squeeze due to high short interest also fuels interest.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as investors flock to the safe-haven asset amid concerns about the government shutdown and broader economic uncertainty. Community chatter highlights gold's potential to reach new highs, with some viewing it as a hedge against potential market downturns or a declining dollar. Discussions also include the relationship between gold, equities, and crypto.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is trending as investors discuss its potential for a short squeeze given the high short interest and recent insider buying, while others are anticipating news from upcoming conferences. Bullish sentiment is fueled by the long-term potential of gene editing and CRISPR's diverse pipeline, including its commercial success with Casgevy. Some traders are eyeing resistance levels, speculating on trial breakthroughs, and monitoring for analyst upgrades as potential catalysts.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential for a short squeeze, citing a small float and high short interest. The community is also focused on upcoming data releases and potential partnerships, viewing the stock as undervalued within the cancer immunotherapy sector. Some are expressing frustration with the stock's performance despite positive clinical data.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending after announcing a commercial agreement with Verizon to bring satellite-based cellular broadband to the US by 2026, driving excitement about the company's potential. Community members are actively discussing the partnership's implications, potential revenue, and the possibility of a short squeeze, while some are wary of the high valuation. The stock's surge reflects broader interest in the space-based communications sector.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital (ATON) is trending due to its focus on tokenizing its mesothelioma treatment program and merging blockchain technology with cancer therapeutics, sparking debate about the company's direction. Community discussions revolve around potential pump-and-dump schemes and the stock's volatility, while some see opportunity in its unique approach to decentralized science. ATON's movements are also being compared to other volatile stocks like XBIO, NXL and ECDA, with traders actively seeking the next high-potential runner.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ASTH vs. USPH: Which Stock Is the Better Value Option?

Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise 

A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.


ASTH or USPH: Which Is the Better Value Stock Right Now?

Zacks.com featured highlights include Astrana Health, BJ's Restaurants, KT Corporation and Global Ship Lease

Astrana Health, BJ's Restaurants, KT Corporation, and Global Ship Lease shine with low EV-to-EBITDA ratios and strong earnings growth outlooks.

Pick These 5 Bargain Stocks With Impressive EV-to-EBITDA Ratios

ASTH, BJRI, ADT, KT and GSL stand out with low EV-to-EBITDA ratios and strong earnings growth forecasts.

Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of -47.22% and +2.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks

Value investors can consider buying high earnings yield stocks like B, ASTH, STNE, PHIN and PAGP for handsome returns.

ASTH vs. CHE: Which Stock Is the Better Value Option?

Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 97.3% in Astrana Health, Inc. (ASTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks.com featured highlights Astrana Health, KT, Upbound, Noah Holdings and DXP Enterprises

ASTH, KT, UPBD, NOAH, and DXPE all boast low EV-toEBITDA ratios and rising earnings estimates, making them standout value plays.

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.

Astrana Health Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$31.02
Prev Close	$30.33
Open	$30.68
Dividend Yield	0.00%
50-Day Moving Average	$28.36
Beta	0.96
Avg. Volume	366,654.57
PE Ratio	58.76

52-Week High	$63.20
52-Week Low	$21.20
Market Capitalization	$1.51B
EPS (Annual)	$0.8994
Price to Book	1.95
Revenue Per Employee	$1.07M
Enterprise Value/EBITDA	N/A

ASTH
Astrana Health Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASTH News

ASTH Astrana Health Inc.